Kongressthemen
Advance Gene Engineering, Persistence, and Scalable Expansion of NK, Gamma-Delta T, and NKT Cell Therapies to Develop Cost-Effective Allogeneic Treatments for Liquid and Solid Tumors
2020 has been a game-changing year for the NK cell community. Positive clinical results have forced the field to wake up to the potential of these pioneering approaches. However, this increased clinical understanding highlights the challenges in producing long-lasting, scalable products.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
URL:
Brochure: https://go.evvnt.com/710015-0?pid=4832
Speakers: Matthew Klinker, Biologist, Cell Therapy Branch, Division of Cellular and Gene Therapies, CBER, Chris Nowers, CEO, ONK Therapeutics, Kurt Gunter, CMO, Kuur Therapeutics and more.
https://go.evvnt.com/710015-1?pid=4832
Herr Innate Killer Summit Team
KategorienAllgemeinmedizin
